WASHINGTON, D.C.—An imaging technique that combines MRI and transrectal ultrasound (MRI-TRUS) is feasible for performing targeted prostate biopsies. This approach may have some advantages over traditional biopsy methods, researchers said here at the Society of Interventional Radiology annual meeting.
Post-transplant distal limb syndrome (PTDLS), an uncommon complication in renal transplant recipients, is associated with a rise in alkaline phosphatase, a finding that could aid in diagnosis, according to researchers.
ORLANDO—Men who have PSA levels below 3 ng/mL at age 75-80 years may be able to safely discon-tinue regular prostate cancer screenings, according to researchers.
WASHINGTON, D.C.—Cryoablation is an appropriate option for patients with unresectable renal masses, but long-term follow-up studies are needed before this modality can be expanded to treatment of all potential surgical candidates, researchers say.
SAN DIEGO—Dutch researchers say that they have identified potential biomarkers which might help physicians monitor the effectiveness of bevacizumab in non-small-cell lung cancer (NSCLC) patients and in patients with advanced kidney cancer treated with sunitinib.
WASHINGTON, D.C.—An imaging modality called cone beam CT may improve intraprocedural management decisions during percutaneous nephrolithotripsy (PCNL), researchers say.
SAN DIEGO—Dutch researchers have reported preliminary success with a combination of the GVAX immunotherapeutic vaccine and ipilimumab (MDX-010, Medarex, Inc) in patients with metastatic hormone-refractory prostate cancer.
SAN DIEGO—Growth hormones commonly used by older men may raise cancer mortality risk significantly.
Holmium laser enucleation of the prostate (HoLEP) is safe and effective for treating symptomatic BPH independent of prostate size, according to a report in BJU International (2008;101:1536-1541).
The FDA posted on its Web site a letter sent to Shire Development, Inc., of Wayne, Pa., regarding promotional materials for its Fosrenol (lanthanum carbonate) chewable tablets for end-stage renal disease.
